Societal CDMO, Inc. Stock Börse Stuttgart
Equities
RAH
US75629F1093
Pharmaceuticals
Sales 2022 | 90.21M 83.03M | Sales 2023 | 94.64M 87.1M | Capitalization | 36.73M 33.8M |
---|---|---|---|---|---|
Net income 2022 | -19M -17.49M | Net income 2023 | -13M -11.96M | EV / Sales 2022 | 1.72 x |
Net Debt 2022 | 29.21M 26.89M | Net Debt 2023 | 34.26M 31.53M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
-4.34
x | P/E ratio 2023 |
-2.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.05% |
Latest transcript on Societal CDMO, Inc.
1st Jan change | Capi. | |
---|---|---|
+59.30% | 846B | |
+38.56% | 628B | |
-4.41% | 360B | |
+17.16% | 322B | |
+9.29% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+13.31% | 173B |